Keywords
Abstract
There has been a steady increase in the number of patients with chronic kidney failure (CKD) worldwide. In CIS countries in the last decade chronic renal insufficiency has been registered with the frequency of 100-600 people per 1 million populations. Since the information on the prevalence of chronic renal failure (CRF) is based on circulating or dialysis center data, the true prevalence of CRF may be underestimated. The following substitution therapies are currently widely used to treat terminal stage chronic kidney disease (CKD): hemodialysis and permanent outpatient peritoneal dialysis, which can significantly prolong the lives of patients. [2, 8, 10]. Over the past five years, the number of patients in the world who are on kidney substitution therapy has increased by more than 25% and currently stands at over 2 million people. The largest growth in the number of such patients was recorded in developing countries (including Uzbekistan) - more than 50% in 5 years [5, 9]. A survey of 102 patients (59 women and 43 men) with CKD of stage 5 was conducted.